Japan Reimburses Zolbetuximab, To Cut Price Of Imfinzi, Others

Impact Of Cost Rules, CEA

 
• By Lisa Takagi
  
Japan announced a series of pricing for new drugs and diagnostics.
Japan announces grants latest group of reimbursement prices • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia